Treatment results and outcome in elderly patients with glioblastoma multiforme - A retrospective single institution analysis

Clinical Neurology and Neurosurgery

Volumn 128, Issue , 2015, Pages 60-69

  Hoffermann, Markus ^a   Bruckmann, Lukas ^a   Mahdy Ali, Kariem ^a   Asslaber, Martin ^a   Payer, Franz ^a   Von Campe, Gord ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Elderly; Extent of resection; Glioblastoma; Malignant Primary Brain Tumors; Temozolomide

Indexed keywords

TEMOZOLOMIDE; ALKYLATING AGENT; DACARBAZINE;

AGED; ARTICLE; BRAIN BIOPSY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; IRRADIATION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NEUROSURGERY; OVERALL SURVIVAL; PARTIAL RESECTION; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; SUBTOTAL RESECTION; TREATMENT OUTCOME; VERY ELDERLY; AGE; ANALOGS AND DERIVATIVES; CANCER GRADING; KARNOFSKY PERFORMANCE STATUS; MORTALITY; SUPRATENTORIAL NEOPLASMS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; GLIOBLASTOMA; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; NEOPLASM GRADING; RETROSPECTIVE STUDIES; SUPRATENTORIAL NEOPLASMS; TREATMENT OUTCOME;

EID: 84911873485     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2014.11.006     Document Type: Article

References (92)

1. N. Ahmadloo, A.A. Kani, M. Mohammadianpanah, H. Nasrolahi, S. Omidvari, and A. Mosalaei Treatment outcome and prognostic factors of adult glioblastoma multiforme J Egypt Natl Canc Inst 25 2013 21 30
2. G.A. Alexiou, A. Goussia, S. Voulgaris, A.D. Fotopoulos, G. Fotakopoulos, and A. Ntoulia Prognostic significance of MRP5 immunohistochemical expression in glioblastoma Cancer Chemother Pharmacol 69 2012 1387 1391
3. C.A. Barker, M. Chang, J.F. Chou, Z. Zhang, K. Beal, and P.H. Gutin Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma J Neurooncol 109 2012 391 397
4. F.G. Barker, M.D. Prados, S.M. Chang, P.H. Gutin, K.R. Lamborn, and D.A. Larson Radiation response and survival time in patients with glioblastoma multiforme J Neurosurg 84 1996 442 448
5. T. Behm, A. Horowski, S. Schneider, H.C. Bock, D. Mielke, and V. Rohde Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients Clin Neurol Neurosurg 115 2013 2142 2146
6. O. Bloch, S.J. Han, S. Cha, M.Z. Sun, M.K. Aghi, and M.W. McDermott Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article J Neurosurg 117 2012 1032 1038
7. A.A. Brandes, and M. Bartolotti Neuro-oncology: treatment decisions in elderly patients with glioblastoma Nat Rev Neurol 8 2012 664 665
8. P.D. Brown, M.J. Maurer, T.A. Rummans, B.E. Pollock, K.V. Ballman, and J.A. Sloan A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival Neurosurgery 57 2005 495 504
9. J.C. Buckner, P.J. Schomberg, W.L. McGinnis, T.L. Cascino, B.W. Scheithauer, and J.R. O'Fallon A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma Cancer 92 2001 420 433
10. G. Catalan-Uribarrena, G. Bilbao-Barandica, I. Pomposo-Gaztelu, J. Undabeitia-Huertas, dG-R. Ruiz, and L. Galbarriatu-Gutierrez Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis Acta Neurochir (Wien) 154 2012 211 222
11. K.L. Chaichana, K.K. Chaichana, A. Olivi, J.D. Weingart, R. Bennett, and H. Brem Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival: clinical article J Neurosurg 114 2011 587 594
12. K.L. Chaichana, T. Garzon-Muvdi, S. Parker, J.D. Weingart, A. Olivi, and R. Bennett Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patients Ann Surg Oncol 18 2011 239 245
13. S.M. Chang, I.F. Parney, W. Huang, F.A. Anderson Jr., A.L. Asher, and M. Bernstein Patterns of care for adults with newly diagnosed malignant glioma JAMA 293 2005 557 564
14. L. Chen, H. Guerrero-Cazares, X. Ye, E. Ford, T. McNutt, and L. Kleinberg Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection Int J Radiat Oncol Biol Phys 86 2013 616 622
15. O.L. Chinot, M. Barrie, E. Frauger, H. Dufour, D. Figarella-Branger, and J. Palmari Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations Cancer 100 2004 2208 2214
16. W.J. Curran Jr., C.B. Scott, J. Horton, J.S. Nelson, A.S. Weinstein, and D.F. Nelson Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials J Neurooncol 12 1992 219 227
17. N. Dea, M.P. Fournier-Gosselin, D. Mathieu, P. Goffaux, and D. Fortin Does extent of resection impact survival in patients bearing glioblastoma? Can J Neurol Sci 39 2012 632 637
18. J. Duntze, C.F. Litre, C. Eap, E. Theret, A. Debreuve, and N. Jovenin Implanted carmustine wafers followed by concomitant radiochemotherapy to treat newly diagnosed malignant gliomas: prospective, observational, multicenter study on 92 cases Ann Surg Oncol 20 2013 2065 2072
19. C. Ewelt, M. Goeppert, M. Rapp, H.J. Steiger, W. Stummer, and M. Sabel Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival J Neurooncol 103 2011 611 618
20. J. Felsberg, M. Rapp, S. Loeser, R. Fimmers, W. Stummer, and M. Goeppert Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients Clin Cancer Res 15 2009 6683 6693
21. P.M. Fernandez, and S. Brem Malignant brain tumors in the elderly Clin Geriatr Med 13 1997 327 338
22. J. Gallego Perez-Larraya, F. Ducray, O. Chinot, I. Catry-Thomas, L. Taillandier, and J.S. Guillamo Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial J Clin Oncol 29 2011 3050 3055
23. J. Gerstein, K. Franz, J.P. Steinbach, V. Seifert, C. Rodel, and C. Weiss Radiochemotherapy with temozolomide for patients with glioblastoma. Prognostic factors and long-term outcome of unselected patients from a single institution Strahlenther Onkol 187 2011 722 728
24. S. Gulati, A.S. Jakola, T.B. Johannesen, and O. Solheim Survival and treatment patterns of glioblastoma in the elderly: a population-based study World Neurosurg 78 2012 518 526
25. A. Gutenberg, H.C. Bock, G. Reifenberger, W. Bruck, and A. Giese Toxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysis Acta Neurochir (Wien) 155 2013 429 435
26. H.G. Hollerhage, M. Zumkeller, M. Becker, and H. Dietz Influence of type and extent of surgery on early results and survival time in glioblastoma multiforme Acta Neurochir (Wien) 113 1991 31 37
27. A. Huber, H. Beran, A. Becherer, N. Prosenc, and A. Witzmann Supratentorial glioma: analysis of clinical and temporal parameters in 163 cases Neurochirurgia (Stuttg) 36 1993 189 193
28. T.A. Hutchinson, N.F. Boyd, A.R. Feinstein, A. Gonda, D. Hollomby, and B. Rowat Scientific problems in clinical scales, as demonstrated in the Karnofsky index of performance status J Chronic Dis 32 1979 661 666
29. F.M. Iwamoto, A.R. Cooper, A.S. Reiner, L. Nayak, and L.E. Abrey Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center Experience (1997-2007) Cancer 115 2009 3758 3766
30. A.S. Jakola, S. Gulati, C. Weber, G. Unsgard, and O. Solheim Postoperative deterioration in health related quality of life as predictor for survival in patients with glioblastoma: a prospective study PLoS One 6 2011 e28592
31. B. Jeremic, D. Grujicic, V. Antunovic, L. Djuric, M. Stojanovic, and Y. Shibamoto Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach J Neurooncol 21 1994 177 185
32. G. Kaloshi, D. Psimaras, K. Mokhtari, C. Dehais, C. Houillier, and Y. Marie Supratentorial low-grade gliomas in older patients Neurology 73 2009 2093 2098
33. F. Keime-Guibert, O. Chinot, L. Taillandier, S. Cartalat-Carel, M. Frenay, and G. Kantor Radiotherapy for glioblastoma in the elderly N Engl J Med 356 2007 1527 1535
34. G.E. Keles, B. Anderson, and M.S. Berger The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere Surg Neurol 52 1999 371 379
35. G.E. Keles, E.F. Chang, K.R. Lamborn, T. Tihan, C.J. Chang, and S.M. Chang Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma J Neurosurg 105 2006 34 40
36. A. Kowalczuk, R.L. Macdonald, C. Amidei, G. Dohrmann III, R.K. Erickson, and J. Hekmatpanah Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas Neurosurgery 41 1997 1028 1036
37. D. Kuhnt, A. Becker, O. Ganslandt, M. Bauer, M. Buchfelder, and C. Nimsky Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance Neuro Oncol 13 2011 1339 1348
38. M. Kurimoto, S. Nagai, H. Kamiyama, Y. Tsuboi, K. Kurosaki, and N. Hayashi Prognostic factors in elderly patients with supratentorial malignant gliomas Neurol Med Chir (Tokyo) 47 2007 543 549
39. M. Lacroix, D. bi-Said, D.R. Fourney, Z.L. Gokaslan, W. Shi, and F. DeMonte A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival J Neurosurg 95 2001 190 198
40. K.R. Lamborn, S.M. Chang, and M.D. Prados Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis Neuro Oncol 6 2004 227 235
41. T. Langsenlehner, M.J. Groll, F. Quehenberger, F. Payer, M. Mokry, and K.S. Kapp Interdisciplinary treatment of glioblastoma: analysis of prognostic factors and treatment results in unselected patients Neoplasma 59 2012 662 668
42. E. Lechapt-Zalcman, G. Levallet, A.E. Dugue, A. Vital, M.D. Diebold, and P. Menei O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide Cancer 118 2012 4545 4554
43. V.A. Levin, W.K. Yung, J. Bruner, A. Kyritsis, N. Leeds, and M.J. Gleason Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas Int J Radiat Oncol Biol Phys 53 2002 58 66
44. D.R. Macdonald, T.L. Cascino, S.C. Schold Jr., and J.G. Cairncross Response criteria for phase II studies of supratentorial malignant glioma J Clin Oncol 8 1990 1277 1280
45. N. Mackworth, P. Fobair, and M.D. Prados Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores J Neurooncol 14 1992 243 253
46. A. Malmstrom, B.H. Gronberg, C. Marosi, R. Stupp, D. Frappaz, and H. Schultz Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial Lancet Oncol 13 2012 916 926
47. R. Martinez, M. Janka, F. Soldner, and R. Behr Gross-total resection of malignant gliomas in elderly patients: implications in survival Zentralbl Neurochir 68 2007 176 181
48. M.J. McGirt, K.L. Chaichana, M. Gathinji, F.J. Attenello, K. Than, and A. Olivi Independent association of extent of resection with survival in patients with malignant brain astrocytoma J Neurosurg 110 2009 156 162
49. G. Minniti, S. De, V. Muni, R. Filippone, F. Bozzao, and A. Valeriani Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients J Neurooncol 88 2008 97 103
50. D.S. Mohan, J.H. Suh, J.L. Phan, P.A. Kupelian, B.H. Cohen, and G.H. Barnett Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution Int J Radiat Oncol Biol Phys 42 1998 981 987
51. T. Nitta, and K. Sato Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas Cancer 75 1995 2727 2731
52. H. Ohgaki, and P. Kleihues Epidemiology and etiology of gliomas Acta Neuropathol 109 2005 93 108
53. D. Orringer, D. Lau, S. Khatri, G.J. Zamora-Berridi, K. Zhang, and C. Wu Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival J Neurosurg 117 2012 851 859
54. A. Oszvald, E. Guresir, M. Setzer, H. Vatter, C. Senft, and V. Seifert Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age J Neurosurg 116 2012 357 364
55. R.V. Patwardhan, C. Shorter, B.K. Willis, P. Reddy, D. Smith, and G.C. Caldito Survival trends in elderly patients with glioblastoma multiforme: resective surgery, radiation, and chemotherapy Surg Neurol 62 2004 207 213
56. T.L. Phillips, V.A. Levin, D.K. Ahn, P.H. Gutin, R.L. Davis, and C.B. Wilson Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study Int J Radiat Oncol Biol Phys 21 1991 709 714
57. W.B. Pope, J. Sayre, A. Perlina, J.P. Villablanca, P.S. Mischel, and T.F. Cloughesy MR imaging correlates of survival in patients with high-grade gliomas AJNR Am J Neuroradiol 26 2005 2466 2474
58. M.D. Prados, P.H. Gutin, T.L. Phillips, W.M. Wara, D.A. Larson, and P.K. Sneed Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989 Int J Radiat Oncol Biol Phys 23 1992 3 8
59. V.K. Puduvalli, M. Hashmi, L.D. McAllister, V.A. Levin, K.R. Hess, and M. Prados Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival Oncology 65 2003 259 266
60. D.S. Raysi, P.D. De, S. Marzi, A. Ricci, A. Cimini, and M.G. Cifone Survival prognostic factors in patients with glioblastoma: our experience J Neurosurg Sci 56 2012 239 245
61. W. Roa, P.M. Brasher, G. Bauman, M. Anthes, E. Bruera, and A. Chan Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial J Clin Oncol 22 2004 1583 1588
62. M. Salvati, A. Pichierri, M. Piccirilli, G.M. Floriana Brunetto, A. D'Elia, and S. Artizzu Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients J Neurosurg 117 2012 204 211
63. N. Sanai, M.Y. Polley, M.W. McDermott, A.T. Parsa, and M.S. Berger An extent of resection threshold for newly diagnosed glioblastomas J Neurosurg 115 2011 3 8
64. J.G. Scott, J.H. Suh, P. Elson, G.H. Barnett, M.A. Vogelbaum, and D.M. Peereboom Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases Neuro Oncol 13 2011 428 436
65. M. Seiz, U. Krafft, C.F. Freyschlag, C. Weiss, K. Schmieder, and F. Lohr Long-term adjuvant administration of temozolomide in patients with glioblastoma multiforme: experience of a single institution J Cancer Res Clin Oncol 136 2010 1691 1695
66. C. Senft, K. Franz, C.T. Ulrich, A. Bink, A. Szelenyi, and T. Gasser Low field intraoperative MRI-guided surgery of gliomas: a single center experience Clin Neurol Neurosurg 112 2010 237 243
67. K. Shirai, Y. Suzuki, M. Okamoto, M. Wakatsuki, S.E. Noda, and T. Takahashi Influence of histological subtype on survival after combined therapy of surgery and radiation in WHO grade 3 glioma J Radiat Res 51 2010 589 594
68. J.R. Simpson, J. Horton, C. Scott, W.J. Curran, P. Rubin, and J. Fischbach Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials Int J Radiat Oncol Biol Phys 26 1993 239 244
69. A.M. Stark, A. Nabavi, H.M. Mehdorn, and U. Blomer Glioblastoma multiforme-report of 267 cases treated at a single institution Surg Neurol 63 2005 162 169
70. W. Stummer, T. Meinel, C. Ewelt, P. Martus, O. Jakobs, and J. Felsberg Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery J Neurooncol 108 2012 89 97
71. W. Stummer, H.J. Reulen, T. Meinel, U. Pichlmeier, W. Schumacher, and J.C. Tonn Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias Neurosurgery 62 2008 564 576
72. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, and M.J. Taphoorn Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
73. A. Tortosa, N. Vinolas, S. Villa, E. Verger, J.M. Gil, and M. Brell Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas Cancer 97 2003 1063 1071
74. Y. Ushio, M. Kochi, J. Hamada, Y. Kai, and H. Nakamura Effect of surgical removal on survival and quality of life in patients with supratentorial glioblastoma Neurol Med Chir (Tokyo) 45 2005 454 460
75. T. Uzuka, H. Aoki, M. Natsumeda, H. Takahashi, and Y. Fujii Effectiveness of maximal safe resection for glioblastoma including elderly and low Karnofsky performance status patients: retrospective review at a single institute Neurol Med Chir (Tokyo) 52 2012 570 576
76. M.J. van den Bent, H.J. Dubbink, M. Sanson, C.R. van der Lee-Haarloo, M. Hegi, and J.W. Jeuken MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951 J Clin Oncol 27 2009 5881 5886
77. C.J. Vecht, C.J. Avezaat, W.L. van Putten, W.M. Eijkenboom, and S.Z. Stefanko The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients J Neurol Neurosurg Psychiatry 53 1990 466 471
78. V. Vuorinen, S. Hinkka, M. Farkkila, and J. Jaaskelainen Debulking or biopsy of malignant glioma in elderly people - a randomised study Acta Neurochir (Wien) 145 2003 5 10
79. Y. Watanabe, F. Yamasaki, Y. Kajiwara, T. Saito, T. Nishimoto, and C. Bartholomeusz Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis J Neurooncol 100 2010 449 457
80. F.M. Wehming, B. Wiese, M. Nakamura, M. Bremer, J.H. Karstens, and A. Meyer Malignant glioma grade 3 and 4: how relevant is timing of radiotherapy? Clin Neurol Neurosurg 114 2012 617 621
81. M. Weller, R. Stupp, M.E. Hegi, B.M. van den, J.C. Tonn, and M. Sanson Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice Neuro Oncol 14 Suppl 4 2012 iv100 iv108
82. P.Y. Wen, D.R. Macdonald, D.A. Reardon, T.F. Cloughesy, A.G. Sorensen, and E. Galanis Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group J Clin Oncol 28 2010 1963 1972
83. M.H. Werner, S. Phuphanich, and G.H. Lyman The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly Cancer 76 1995 1634 1642
84. W. Wick, C. Hartmann, C. Engel, M. Stoffels, J. Felsberg, and F. Stockhammer NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide J Clin Oncol 27 2009 5874 5880
85. W. Wick, M. Platten, C. Meisner, J. Felsberg, G. Tabatabai, and M. Simon Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial Lancet Oncol 13 2012 707 715
86. T. Xu, R. Qin, J. Zhou, Y. Yan, Y. Lu, and X. Zhang High bone sialoprotein (BSP) expression correlates with increased tumor grade and predicts a poorer prognosis of high-grade glioma patients PLoS One 7 2012 e48415
87. S. Yamaguchi, H. Kobayashi, S. Terasaka, N. Ishii, J. Ikeda, and H. Kanno The impact of extent of resection and histological subtype on the outcome of adult patients with high-grade gliomas Jpn J Clin Oncol 42 2012 270 277
88. W. Yan, W. Zhang, G. You, Z. Bao, Y. Wang, and Y. Liu Correlation of IDH1 mutation with clinicopathologic factors and prognosis in primary glioblastoma: a report of 118 patients from China PLoS One 7 2012 e30339
89. P. Yang, Y. Wang, X. Peng, G. You, W. Zhang, and W. Yan Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution J Neurooncol 113 2013 259 266
90. E.I. Zacharaki, N. Morita, P. Bhatt, D.M. O'Rourke, E.R. Melhem, and C. Davatzikos Survival analysis of patients with high-grade gliomas based on data mining of imaging variables AJNR Am J Neuroradiol 33 2012 1065 1071
91. I. Zachenhofer, R. Maier, H. Eiter, M. Muxel, M. Cejna, and A. DeVries Overall survival and extent of surgery in adult versus elderly glioblastoma patients: A population based retrospective study Wien Klin Wochenschr 123 2011 364 368
92. P.O. Zinn, R.R. Colen, E.M. Kasper, and J.K. Burkhardt Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients Int J Oncol 42 2013 929 934